Chemical Bank raised its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) by 7.6% during the 1st quarter, HoldingsChannel.com reports. The firm owned 16,935 shares of the medical research company’s stock after acquiring an additional 1,191 shares during the quarter. Chemical Bank’s holdings in Thermo Fisher Scientific were worth $4,635,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. CX Institutional purchased a new stake in shares of Thermo Fisher Scientific during the first quarter worth about $36,000. Freestone Capital Holdings LLC increased its position in shares of Thermo Fisher Scientific by 46.1% during the fourth quarter. Freestone Capital Holdings LLC now owns 10,081 shares of the medical research company’s stock worth $2,256,000 after acquiring an additional 3,180 shares during the last quarter. Putnam FL Investment Management Co. increased its position in shares of Thermo Fisher Scientific by 2.9% during the fourth quarter. Putnam FL Investment Management Co. now owns 29,001 shares of the medical research company’s stock worth $6,490,000 after acquiring an additional 810 shares during the last quarter. Buckingham Asset Management LLC increased its position in shares of Thermo Fisher Scientific by 6.9% during the first quarter. Buckingham Asset Management LLC now owns 2,106 shares of the medical research company’s stock worth $576,000 after acquiring an additional 136 shares during the last quarter. Finally, Steinberg Global Asset Management increased its position in shares of Thermo Fisher Scientific by 21.1% during the first quarter. Steinberg Global Asset Management now owns 5,747 shares of the medical research company’s stock worth $1,187,000 after acquiring an additional 1,000 shares during the last quarter. 88.43% of the stock is currently owned by institutional investors.

NYSE:TMO opened at $271.80 on Friday. The stock has a market capitalization of $108.71 billion, a P/E ratio of 24.44, a PEG ratio of 1.74 and a beta of 1.11. Thermo Fisher Scientific Inc. has a one year low of $202.83 and a one year high of $282.98. The company has a debt-to-equity ratio of 0.61, a current ratio of 1.69 and a quick ratio of 1.16.

Thermo Fisher Scientific (NYSE:TMO) last posted its quarterly earnings results on Wednesday, April 24th. The medical research company reported $2.81 EPS for the quarter, topping the Zacks’ consensus estimate of $2.74 by $0.07. The business had revenue of $6.13 billion during the quarter, compared to the consensus estimate of $6.04 billion. Thermo Fisher Scientific had a return on equity of 17.06% and a net margin of 12.89%. The company’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same period last year, the firm earned $2.50 earnings per share. On average, analysts predict that Thermo Fisher Scientific Inc. will post 12.2 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, July 16th. Investors of record on Friday, June 14th will be paid a $0.19 dividend. The ex-dividend date of this dividend is Thursday, June 13th. This represents a $0.76 dividend on an annualized basis and a yield of 0.28%. Thermo Fisher Scientific’s dividend payout ratio (DPR) is 6.83%.

In other Thermo Fisher Scientific news, CEO Marc N. Casper sold 50,713 shares of Thermo Fisher Scientific stock in a transaction that occurred on Tuesday, April 30th. The stock was sold at an average price of $273.21, for a total value of $13,855,298.73. Following the completion of the transaction, the chief executive officer now directly owns 302,193 shares in the company, valued at $82,562,149.53. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, SVP Gregory J. Herrema sold 19,808 shares of Thermo Fisher Scientific stock in a transaction that occurred on Monday, February 25th. The shares were sold at an average price of $253.29, for a total value of $5,017,168.32. Following the completion of the transaction, the senior vice president now owns 25,688 shares of the company’s stock, valued at $6,506,513.52. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 76,320 shares of company stock valued at $20,405,269. 0.45% of the stock is currently owned by insiders.

A number of analysts have recently issued reports on TMO shares. Zacks Investment Research lowered Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a research report on Tuesday, May 14th. Barclays lifted their target price on Thermo Fisher Scientific from $295.00 to $300.00 and gave the stock an “overweight” rating in a research report on Monday, March 18th. Deutsche Bank lifted their price target on Thermo Fisher Scientific from $275.00 to $300.00 and gave the stock a “buy” rating in a research note on Friday, March 22nd. UBS Group lifted their price target on Thermo Fisher Scientific from $305.00 to $320.00 and gave the stock a “buy” rating in a research note on Thursday. Finally, Robert W. Baird lifted their price target on Thermo Fisher Scientific from $270.00 to $288.00 and gave the stock an “outperform” rating in a research note on Tuesday, March 26th. Two analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company’s stock. Thermo Fisher Scientific presently has an average rating of “Buy” and an average target price of $295.92.

ILLEGAL ACTIVITY NOTICE: “Chemical Bank Grows Holdings in Thermo Fisher Scientific Inc. (TMO)” was published by Daily Political and is the sole property of of Daily Political. If you are accessing this piece of content on another domain, it was illegally stolen and reposted in violation of U.S. and international copyright laws. The original version of this piece of content can be viewed at https://www.dailypolitical.com/2019/05/25/chemical-bank-grows-holdings-in-thermo-fisher-scientific-inc-tmo.html.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.

See Also: What is an SEC Filing?

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.